Ciclopirox
NDC 45802-141, Ciclopirox, solution, from Padagis Israel Pharmaceuticals Ltd.
- Product NDC
- 45802-141
- Status
- Listed
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Dosage form
- SOLUTION
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077623
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/45802-141 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CICLOPIROX80 mg/mL
Pharmacologic classes
Decreased DNA Replication [PE]; Decreased Protein Synthesis [PE]; Decreased RNA Replication [PE]; Protein Synthesis Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 45802-141-67 | 45802014167 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (45802-141-67) / 6.6 mL in 1 BOTTLE, WITH APPLICATOR |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/02f46b6e-b424-4210-83bf-e79618df4344NADAC price for package 45802014167
GET /v1/drugs/nadac/45802014167
Use it
Look up 45802-141 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/45802-141 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 45802-141. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.